Logo.jpg
Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets
23 août 2022 10h54 HE | Antisense Therapeutics Limited
World first study utilizing Somalogic SomaScan® assay# to assess up to 7,000 plasma proteins in Long COVID-19 patients has elucidated novel blood markers as potential diagnostic and therapeutic...
Logo.jpg
Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets
22 août 2022 07h40 HE | Antisense Therapeutics Limited
World first study utilizing Somalogic SomaScan® assay# to assess up to 7,000 plasma proteins in Long COVID-19 patients has elucidated novel blood markers as potential diagnostic and therapeutic...
image 1
New Muscle Disease Indication for ATL1102 – Limb Girdle Muscular Dystrophy R2
22 juin 2022 09h15 HE | Antisense Therapeutics Limited
LGMDR2, also referred to as dysferlinopathy, is a rare genetic muscle disease caused by mutations in the dysferlin gene (DYSF)Animal study conducted at MCRI in collaboration with Jain Foundation in...